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Abstract
Background Chronic subdural haematoma (CSDH) is a com-
mon condition that is effectively managed by burrhole drain-
age but requires repeat surgery in a significant minority of
patients. The Cambridge Chronic Subdural Haematoma Trial
(CCSHT) was a randomised controlled study that showed
placement of subdural drains for 48 h following burrhole
evacuation significantly reduces the incidence of reoperation
and improves survival at 6 months. The present study exam-
ined the long-term survival of the patients in the trial.
Methods In the original trial patients at a single neurosurgical
centre from 2004–2007 were randomly assigned to receive a
drain (n=108) or no drain (n=107) following burrhole drain-
age of CSDH. We ascertained whether the trial patients were
alive in February 2016—a minimum of 8 years following
enrollment—via the UK NHS tracing service. Survival was
compared between the trial groups and against expected sur-
vival for the UK general population matched for age and sex.
Results At 5 years following surgery the drain group continued to
have significantly better survival than the no drain patients
(p=0.027), but this was no longer apparent at 10 years. Survival
of patients in the drain group did not differ significantly from that
of the general population whereas patients who did not receive a
drain had significantly lower survival than expected (p=0.0006).
Conclusion Subdural drains following CSDH evacuation are
associated with improved long-term survival, which appears
similar to that expected for the general population of the same
age and sex. All patients having burrhole CSDH evacuation
should receive a drain as standard practice unless specifically
contraindicated.
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Introduction
Chronic subdural haematoma (CSDH) is a common condi-
tion, predominantly affecting those over 65 years of age [4].
Symptomatic CSDH is typically managed by surgical evacu-
ation, usually via burrholes or mini-craniotomy, and a signif-
icant minority of patients develop recurrent symptomatic col-
lections that require repeat surgical drainage.
From November 2004 to December 2007 the Cambridge
Chronic Subdural Haematoma (CCSDH) trial randomised pa-
tients to receive a subdural drain for 48 h post-operatively
(n=108) or no drain (n=107), following burrhole evacuation
of CSDH at a single UK neurosurgical centre [7]. The inci-
dence of recurrent CSDH necessitating redrainage was signif-
icantly lower in the patients who received a drain (9.3% vs.
24%, p=0.003) and 6-month mortality was also significantly
reduced (8.6% vs. 18.1%, p=0.042) [7].
Although the prognostic implications of various clinical
features and management factors have been reported in the
literature [5], it remains unknown whether treated CSDH has
an impact on patients’ long-term life expectancy. Patients with
CSDH are generally from an age group with higher baseline
mortality and it is difficult to infer from unadjusted data
whether there is an excess of deaths following CSDH or if
the observed survival curves are comparable to those of the
age- and sex-matched general population.
The objective of this report is to detail the long-term sur-
vival of patients enrolled in the CCSDH trial, with a minimum
The findings of this study were presented at the Society of British
Neurological Surgeons Autumn Meeting, 9 September 2015, York, UK.
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8-year follow-up, and to examine the relative survival of the
study patients in comparison with the UK general population.
Methods
The trial design and protocol, together with detailed demo-
graphic and clinical details of the trial participants, can be found
in the original publication [7]. Briefly, adult patients requiring
evacuation of CSDH were randomly allocated to receive either
a subdural drain or no drain at the end of the burrhole drainage
procedure. Drains were left on free drainage for 48 h prior to
removal on theward. The primary outcomemeasure was symp-
tomatic recurrent CSDHneeding repeat surgery; secondary out-
comes includedmortality and neurological outcome at 6months
following surgery. The trial was prospectively registered
(ISRCTN 97314294) and approved by the UK NHS Research
Ethics Committee. No funding was received for the study.
The survival status of trial patients was ascertained on 1
February 2016 via the UK NHS Strategic Tracing Service.
This was 8 years from the date of enrollment of the last patient
into the trial.
All statistical analysis was performed in R (v.3.2.4, www.r-
project.org) using the survival and relsurv packages [6, 8]
(both available at cran.r-project.org). Survival of the trial
patients was calculated using the Kaplan-Meier method from
the date of surgery. Survival between the study arms was
compared with the two-sample log-rank test.
Life tables for the England and Wales civilian population,
reporting the annual age- (in 1-year increments) and sex-
specific risk of death for the years 1841–2013, were obtained
from the Human Mortality Database (www.mortality.org). Data
for 2013 were used for all later years as this was the most recent
available. Life tables were used to generate representative
cohorts of the general population with the same number of
patients and identical age and sex profiles as the control (no
drain) and drain groups. Relative survival was calculated as the
ratio of observed to expected survival. Statistical comparison of
the observed survival in the trial groups and the expected
survival of respective population cohorts was performed with
the one-sample log-rank test [1, 8]. An expected survival curve
for the trial cohort was generated using the conditional (Ederer
II) method [2]. Statistical significance was set at 5%.
Results
Patients in the trial had median age of 78 years (range 35–95)
and 74.4% were male. At baseline the groups were well bal-
anced [6]. At 5 years post-operatively 34.2% of patients in the
drain group and 47.7% in the control group had died; compar-
ison of 5-year survival curves showed a significant reduction in
mortality associated with receiving a drain (χ2=4.9, p=0.027;
Fig 1). There was no significant difference when comparing the
survival curves over 8 years (the time up to which complete
follow-up was possible) or 10 years from surgery.
We then determined the relative survival of the trial groups
against comparable age- and sex- matched cohorts of the gen-
eral population. At 5 years the relative survival in the no drain
group was 77.6% compared with 89.8% in the drain group.
Comparison of the observed survival curves with expected
survival (Fig. 1) found no significant difference in the drain
group (χ2=2.8, p=0.09) but patients who were not treated
with a drain had significantly lower survival than the general
population (χ2 =11.8, p=0.0006).
To exclude the potential bias of post-operative deaths within 6
months of surgery on the analysis of long-term relative survival the
subset of trial patients alive at 6 months (n=187; 98 in the drain
group) was compared with the general population. Five-year rela-
tive survival, conditional on being alive at 6 months (Fig. 2), was
again significantly lower in the control patients (χ2 = 4.9,
p=0.026) but not for the drain group (χ2=0.02, p=0.897).
Discussion
This study builds on the previously reported 6-month out-
comes of a randomised controlled trial of subdural drains fol-
lowing burrhole drainage of CSDH [7]. Patients managed
with a drain had significantly lower mortality at 6 months
post-operatively and the present analysis confirms that a sig-
nificant survival advantage remains at 5 years following sur-
gery. Moreover, patients who received a drain had long-term
survival that was not significantly different from that expected
of the general population. In contrast, patients who did not
receive a drain had significantly worse survival than expected.
Importantly, this was not simply an effect of the higher early
Fig. 1 Kaplan-Meier survival curves for the trial groups (solid lines) with
95% confidence intervals (shaded regions) and the expected survival of a
cohort of the general populationmatched for age and sex to the patients in
the study (dashed line)
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mortality in the control group: patients without a drain who
survived at least 6 months continued to demonstrate lower
relative survival, whereas the conditional survival in the drain
group essentially followed that of the general population.
Subdural drains are effective in reducing the incidence of
residual or recurrent haematoma that require reoperation [7].
By the same mechanism drains presumably also minimise
subclinical recollections that contribute to slower neurological
recovery and rehabilitation. Earlier mobilisation and faster
discharge from hospital avoid the complications of prolonged
inpatient admission and can have a long-term impact on
whether patients regain functional independence. It is well
recognised that reduced performance status and inability to
do activities of daily living are associated with reduced life
expectancy, particularly amongst the elderly [3].
Comparing the observed survival of the trial groups to that of
the general population provides a valuable illustration of the
efficacy of subdural drains over and above direct comparison
of the trial groups. Particularly when trial participants are of a
demographic with higher baseline mortality, calculating relative
survival is a powerfulmethod to detect excess deaths attributable
to a disease or intervention, an inference that would be challeng-
ing to draw simply from inspecting survival curves alone [6].
Limitations of this study include the lack of later functional
outcome assessments; it is not possible to know if the additional
patients surviving in the subdural drain group also had a quality
of life similar to the general population. Despite appearing to
remain essentially parallel, comparisons of group survival
curves beyond 5 years were not significant, reflecting inherent
limits to the statistical power of the sample size in detecting
differences as the number of patients at risk decreased during
later follow-up. Similarly, the absence of a difference between
the observed and expected survival of the drain group in the
present analysis does not preclude that a larger study might
resolve a statistically significant excess mortality.
Overall, the present findings underline the benefits of sub-
dural drains following CSDH evacuation: patients managed
with a drain survive longer and appear to have life expectancy
similar to that of the general population. This evidence en-
dorses the recommendation that standard practice for all
burrhole evacuations of CSDH procedures should include,
when safe, routine insertion of a subdural drain.
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